Small interfering RNA targeting CD81 ameliorated arthritis in rats

Biochemical and Biophysical Research Communications

Volumn 388, Issue 3, 2009, Pages 467-472

  Nakagawa, Shuji ^a   Arai, Yuji ^a   Mori, Hiroki ^b   Matsushita, Yumi ^c   Kubo, Toshikazu ^a   Nakanishi, Tohru ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b SHUJITSU UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

Arthritis; CD81; Collagen induced arthritic rat; In vivo electroporation; Intraarticular injection; siRNA; Synovial tissue; Synoviolin

Indexed keywords

CD81 ANTIGEN; COLLAGEN; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; BONE ATROPHY; BONE EROSION; CONTROLLED STUDY; DRUG EFFECT; ELECTROPORATION; GENE SILENCING; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; SYNOVIUM;

ANIMALS; ANTIGENS, CD; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; RATS; RATS, INBRED STRAINS; RNA, SMALL INTERFERING; SYNOVIAL MEMBRANE; UBIQUITIN-PROTEIN LIGASES;

RATTUS;

EID: 69549098185     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.06.150     Document Type: Article

References (24)

1. Shoenfeld Y., and Isenberg D.A. The mosaic of autoimmunity. Immunol. Today 10 (1989) 123-126
2. Kaur H., Edmonds S.E., Blake D.R., and Halliwell B. Hydroxyl radical generation by rheumatoid blood and knee joint synovial fluid. Ann. Rheum. Dis. 55 (1996) 915-920
3. Elliott M.J., Maini R.N., Feldmann M., Long-Fox A., Charles P., Bijl H., and Woody J.N. Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet 344 (1994) 1125-1127
4. Choy E.H., Isenberg D.A., Garrood T., Farrow S., Ioannou Y., Bird H., Cheung N., Williams B., Hazleman B., Price R., Yoshizaki K., Nishimoto N., Kishimoto T., and Panayi G.S. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum. 46 (2002) 3143-3150
5. Keane J., Gershon S., Wise R.P., Mirabile-Levens E., Kasznica J., Schwieterman W.D., Siegel J.N., and Braun M.M. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 345 (2001) 1098-1104
6. Hampton R.Y., Gardner R.G., and Rine J. Role of 26S proteasome and HRD genes in the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase, an integral endoplasmic reticulum membrane protein. Mol. Biol. Cell 7 (1996) 2029-2044
7. Amano T., Yamasaki S., Yagishita N., Tsuchimochi K., Shin H., Kawahara K., Aratani S., Fujita H., Zhang L., Ikeda R., Fujii R., Miura N., Komiya S., Nishioka K., Maruyama I., Fukamizu A., and Nakajima T. Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathy. Genes Dev. 17 (2003) 2436-2449
8. Levy S., Todd S.C., and Maecker H.T. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu. Rev. Immunol. 16 (1998) 89-109
9. Horikawa K., and Takatsu K. Interleukin-5 regulates genes involved in B-cell terminal maturation. Immunology 118 (2006) 497-508
10. Mori H., and Nakanishi T. Signal transduction of inflammatory synoviocytes in rheumatoid arthritis. Yakugaku Zasshi 128 (2008) 263-268
11. Bakharevski O., Stein-Oakley A.N., Thomson N.M., and Ryan P.F. Collagen induced arthritis in rats. Contrasting effect of subcutaneous versus intradermal inoculation of type II collagen. J. Rheumatol. 25 (1998) 1945-1952
12. Fujisawa K., Aono H., Hasunuma T., Yamamoto K., Mita S., and Nishioka K. Activation of transcription factor NF-kappa B in human synovial cells in response to tumor necrosis factor alpha. Arthritis Rheum. 39 (1996) 197-203
13. Ohashi S., Kubo T., Kishida T., Ikeda T., Takahashi K., Arai Y., Terauchi R., Asada H., Imanishi J., and Mazda O. Successful genetic transduction in vivo into synovium by means of electroporation. Biochem. Biophys. Res. Commun. 293 (2002) 1530-1535
14. Kawahito Y., Kondo M., Tsubouchi Y., Hashiramoto A., Bishop-Bailey D., Inoue K., Kohno M., Yamada R., Hla T., and Sano H. 15-deoxy-delta(12, 14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J. Clin. Invest. 106 (2000) 189-197
15. Weinberger A., Halpern M., Zahalka M.A., Quintana F., Traub L., and Moroz C. Placental immunomodulator ferritin, a novel immunoregulator, suppresses experimental arthritis. Arthritis Rheum. 48 (2003) 846-853
16. Inoue A., Takahashi K.A., Mazda O., Terauchi R., Arai Y., Kishida T., Shin-Ya M., Asada H., Morihara T., Tonomura H., Ohashi S., Kajikawa Y., Kawahito Y., Imanishi J., Kawata M., and Kubo T. Electro-transfer of small interfering RNA ameliorated arthritis in rats. Biochem. Biophys. Res. Commun. 336 (2005) 903-908
17. Russell R.S., Meunier J.C., Takikawa S., Faulk K., Engle R.E., Bukh J., Purcell R.H., and Emerson S.U. Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus. Proc. Natl. Acad. Sci. USA 105 (2008) 4370-4375
18. Dijkstra S., Kooij G., Verbeek R., van der Pol S.M., Amor S., Geisert Jr. E.E., Dijkstra C.D., van Noort J.M., and Vries H.E. Targeting the tetraspanin CD81 blocks monocyte transmigration and ameliorates EAE. Neurobiol. Dis. 31 (2008) 413-421
19. Oka T., Yoshino T., Hayashi K., Ohara N., Nakanishi T., Yamaai Y., Hiraki A., Sogawa C.A., Kondo E., Teramoto N., Takahashi K., Tsuchiyama J., and Akagi T. Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias: combination analysis with cDNA expression array and tissue microarray. Am. J. Pathol. 159 (2001) 1495-1505
20. Takemura S., Braun A., Crowson C., Kurtin P.J., Cofield R.H., O'Fallon W.M., and Goronzy C.M. Lymphoid neogenesis in rheumatoid synovitis. J. Immunol. 167 (2001) 1072-1080
21. Maini R., St Clair E.W., Breedveld F., Furst D., Kalden J., Weisman M., Smolen J., Emery P., Harriman G., Feldmann M., and Lipsky P. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet 354 (1999) 1932-1939
22. Bumcrot D., Manoharan M., Koteliansky V., and Sah D.W. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat. Chem. Biol. 2 (2006) 711-719
23. Braasch D.A., Jensen S., Liu Y., Kaur K., Arar K., White M.A., and Corey D.R. RNA interference in mammalian cells by chemically-modified RNA. Biochemistry 42 (2003) 7967-7975
24. Miyagishi M., and Taira K. Development and application of siRNA expression vector. Nucleic Acids Res. Suppl. (2002) 113-114